1 Min Read
LONDON, July 1 (Reuters) - Hikma Pharmaceuticals PLC : * Signing of an exclusive commercialisation agreement with theravance, inc for
vibativ in the Middle East and North Africa (“MENA”) region
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.